CMP
CLX icon

Coston McIsaac & Partners’s Clorox CLX Stock Holding History

Coston McIsaac & Partners’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.69M Buy
35,601
+5,379
+18% +$610K 0.83% 36
2025
Q4 		$3.05M Sell
30,222
-2,506
-8% -$272K 0.71% 41
2025
Q3 		$4.03M Sell
32,728
-1,060
-3% -$132K 0.96% 35
2025
Q2 		$4.06M Buy
33,788
+430
+1% +$57.4K 1.05% 33
2025
Q1 		$4.91M Sell
33,358
-1,102
-3% -$168K 1.43% 25
2024
Q4 		$5.59M Sell
34,460
-19
-0.1% -$3.11K 1.66% 17
2024
Q3 		$5.62K Buy
34,479
+1,048
+3% +$155K 1.58% 22
2024
Q2 		$4.56M Buy
33,431
+729
+2% +$101K 1.44% 26
2024
Q1 		$5.01M Buy
32,702
+805
+3% +$120K 1.61% 19
2023
Q4 		$4.55M Buy
31,897
+1,014
+3% +$135K 1.58% 21
2023
Q3 		$4.05M Buy
30,883
+1,846
+6% +$281K 1.54% 26
2023
Q2 		$4.62M Buy
29,037
+362
+1% +$58.4K 1.59% 18
2023
Q1 		$4.54M Buy
28,675
+1,731
+6% +$260K 1.69% 17
2022
Q4 		$3.78K Buy
26,944
+2,086
+8% +$296K 1.47% 25
2022
Q3 		$3.19M Buy
24,858
+3,176
+15% +$458K 1.46% 25
2022
Q2 		$3.06M Buy
+21,682
New +$3.1M 1.85% 19

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Coston McIsaac & Partners's CLX Position: Q1 2026 in Review

Coston McIsaac & Partners increased its Clorox (CLX) stake by 18% in Q1 2026, buying an estimated $610K and bringing the position to 35,601 shares worth $3.69M. The position accounts for 0.83% of the portfolio, ranked #36.

Coston McIsaac & Partners first reported a position in CLX in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.59M in Q4 2024. 1,083 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Coston McIsaac & Partners held 35,601 shares of Clorox worth $3.69M as of Q1 2026.
  • Coston McIsaac & Partners bought 5,379 Clorox shares in Q1 2026, an estimated $610K.
  • Clorox made up 0.83% of Coston McIsaac & Partners's portfolio in Q1 2026, its #36 holding.
  • Coston McIsaac & Partners first reported a position in Clorox in Q2 2022 and has held it in 16 quarters since.
  • Coston McIsaac & Partners's Clorox position peaked at $5.59M in Q4 2024.
  • 1,083 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Coston McIsaac & Partners's 13F filing for Q1 2026, filed 22 Apr 2026.